Landec Corp. (NASDAQ:LNDC)’s share price shot up 3.4% during trading on Friday . The stock traded as high as $11.00 and last traded at $10.99, with a volume of 51,160 shares trading hands. The stock had previously closed at $10.63.

Several research firms have recently commented on LNDC. Zacks Investment Research raised Landec Corp. from a “sell” rating to a “hold” rating in a report on Tuesday, May 3rd. Wedbush assumed coverage on Landec Corp. in a research report on Thursday, July 7th. They set a “neutral” rating and a $12.00 price objective for the company. Finally, Maxim Group assumed coverage on Landec Corp. in a research report on Tuesday, June 7th. They set a “buy” rating and a $16.00 price objective for the company. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $15.10.

The stock’s market capitalization is $308.36 million. The firm has a 50 day moving average price of $11.01 and a 200-day moving average price of $11.02.

An institutional investor recently raised its position in Landec Corp. stock. Heartland Advisors Inc. increased its stake in shares of Landec Corp. (NASDAQ:LNDC) by 5.9% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 936,452 shares of the company’s stock after buying an additional 52,509 shares during the period. Heartland Advisors Inc. owned about 3.46% of Landec Corp. worth $11,078,000 as of its most recent filing with the SEC.

Landec Corporation designs, develops, manufactures and sells differentiated products for food and biomaterials markets and licenses technology applications to partners. The Company’s segments include Food Products Technology, Food Export and Hyaluronan-based Biomaterials. The Company’s Food Products Technology segment markets and packs specialty packaged whole and fresh-cut fruit and vegetables.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.